Jonathon B. Cohen, MD

Articles by Jonathon B. Cohen, MD

Overcoming Challenges in Treating MCL

November 20th 2018

Jonathon B. Cohen, MD, discusses the biggest challenge in treating mantle cell lymphoma and how these challenges can be overcome.

Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas

ByJonathon B. Cohen, MD

September 28th 2018

Jonathon B. Cohen, MD, discusses findings from a study of polatuzumab vedotin, an anti-CD79b antibody-drug conjugate, with bendamustine and rituximab in patients with aggressive lymphomas.

Latest Updated Articles

Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas
Published: September 28th 2018 | Updated:
Overcoming Challenges in Treating MCL
Published: November 20th 2018 | Updated:

Jonathon B. Cohen, MD

Articles by Jonathon B. Cohen, MD

Overcoming Challenges in Treating MCL

Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma